Colucid Pharma Cmn (CLCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLCD | LENZ | ETNB | ||
| Company | Colucid Pharma Cmn | Lenz Therapeutics Inc | 89Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 46.50 | 34.00 | 8.85 | ||
| High | 46.55 | 34.00 | 8.85 | ||
| Low | 46.45 | 31.59 | 7.85 | ||
| Last | 46.53 | 33.20 | 7.93 | ||
| Change | +0.03 | -0.73 | -0.82 | ||
| % Change | +0.06% | -2.15% | -9.37% | ||
| Volume | 127,000 | 172,300 | 1,433,900 | ||
| 20-Day Average Volume | 245,780 | 185,580 | 901,780 | ||
| Previous Close | 46.50 | 33.93 | 8.75 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 46.44 | 30.09 | 8.73 | ||
| 20-Day Raw Stochastic | 70.00% | 63.76% | 8.52% | ||
| 20-Day Relative Strength | 67.22% | 61.55% | 45.03% | ||
| Weighted Alpha | +162.70 | +130.63 | -4.33 | ||
| Today's Opinion | N/A | 100% Buy | 64% Sell | ||
| Previous Opinion | N/A | 100% Buy | Hold | ||
| Last Month's Opinion | N/A | 100% Buy | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.06% since 02/21/17 | -5.33% since 11/08/24 | -24.11% since 11/08/24 | ||
| Low | 46.45 on 02/28/17 | 31.59 on 11/15/24 | 7.85 on 11/15/24 | ||
| High | 46.55 on 02/28/17 | 38.93 on 11/13/24 | 10.72 on 11/11/24 | ||
| 1-Month | |||||
| %Chg | +0.61% since 01/27/17 | +26.57% since 10/15/24 | -1.12% since 10/15/24 | ||
| Low | 46.20 on 01/30/17 | 23.12 on 10/23/24 | 7.67 on 11/01/24 | ||
| High | 46.65 on 02/08/17 | 38.93 on 11/13/24 | 10.72 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +37.26% since 11/28/16 | +46.90% since 08/15/24 | -2.94% since 08/15/24 | ||
| Low | 31.25 on 01/06/17 | 19.90 on 09/12/24 | 7.00 on 10/03/24 | ||
| High | 46.65 on 02/08/17 | 38.93 on 11/13/24 | 10.72 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +441.05% since 08/26/16 | +109.60% since 05/15/24 | -13.80% since 05/15/24 | ||
| Low | 8.65 on 08/29/16 | 14.42 on 06/04/24 | 7.00 on 10/03/24 | ||
| High | 46.65 on 02/08/17 | 38.93 on 11/13/24 | 10.72 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 897,098 | 913,033 | 841,579 | ||
| Shares Outstanding, K | 19,280 | 27,501 | 106,126 | ||
| Annual Sales | 0 | 15,000,000 | 0 | ||
| Annual Net Income | -30,740,000 | -124,650,000 | -142,190,000 | ||
| Last Quarter Sales | N/A | 0 | 0 | ||
| Last Quarter Net Income | N/A | -10,220,000 | -149,070,000 | ||
| 60-Month Beta | 1.51 | 0.36 | 1.07 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.38 on 11/06/24 | -1.39 on 11/07/24 | ||
| Latest Earnings Date | 03/01/17 | 11/06/24 | 11/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||